Neurology Devices Market Outlook (2025 to 2035)
The global neurology device market was valued at USD 10,944.3 million in 2024 and has been forecasted to expand at a noteworthy CAGR of 6.7% to end up at USD 22,335.5 million by 2035.
Neurological devices serve for diagnosing diseases and preventing disorders and treating conditions that include Alzheimer's disease as well as Parkinson's disease, major depression, epilepsy and spinal cord injury & traumatic brain injury.
Neurological devices return hearing and sight capabilities while enhancing the functions of people with lost limbs or those born with such differences. The classification of neurological devices contains neuro-diagnostics alongside neurointerventional and neurostimulation devices.
The FDA's Center for Devices and Radiological Health assists developers along with manufacturers to drive innovation while ensuring that medical devices reach US patients as the first worldwide.
The organization performs regulatory research for medical devices to facilitate their creation as well as continuous monitoring of existing market devices for safety purposes. Through its regulatory initiatives the FDA seeks to improve the neurological medical device development process by making it more open and foreseeable to developers and innovators.
| Report Attributes |
Details |
| Neurology Devices Market Size (2024A) |
USD 10,944 Million |
| Estimated Market Value (2025E) |
USD 11,678 Million |
| Expected Market Value (2035F) |
USD 22,336 Million |
| Global Market Growth Rate (2025 to 2035) |
6.7% CAGR |
| East Asia Market Share (2025) |
18.9% |
| China Market Growth Rate (2025 to 2035) |
6.5% CAGR |
| Key Companies Profiled |
Medtronic; Boston Scientific Corporation; Stryker Corporation; Abbott Laboratories; Johnson & Johnson (DePuy Synthes); Penumbra, Inc.; MicroPort Scientific Corporation; Terumo Corporation; Nihon Kohden Corporation; Integra LifeSciences Holdings Corp; Elekta AB; LivaNova PLC; NeuroPace, Inc.; NeuroSigma, Inc.; BrainsWay Ltd.; Other Prominent Players. |
Historic Analysis (2020 to 2024) and Future (2025 to 2035) Pathway Analysis for the Neurology Devices Market
The neurology devices market saw considerable growth from 2020 to 2024 because medical professionals became more aware about neurological conditions while new innovative treatments appeared on the market. The neurology devices market witnessed substantial growth because technological improvements introduced minimally invasive approaches along with artificial intelligence tools which resulted in better patient care and market expansion.
- Short Term (2025 to 2028): The market shows sustained expansion over short-term predictions because of growing interest in minimal procedures and artificial intelligence diagnostic systems. Neurostimulation devices are anticipated to become more common because of their increasing use in chronic pain and movement disorder treatment. A rising number of research and development investments will create new innovative products which will propel market expansion forward.
- Medium Term (2028 to 2032): The future will direct attention toward customized medical treatments based on individual patient specifications. Future developments in neuroprosthetics alongside brain-computer interface technology (BCIs) will create potential treatment solutions which target paralysis symptoms together with neurodegenerative diseases. The partnership of medical device companies and technology firms will speed up both research and development in their fields during this period.
- Long Term (2032 to 2035): The normal integration of neurology devices with digital health platforms will become standard in this timeframe because it allows remote monitoring and telemedicine benefits. The growth of emerging markets will be the primary driver of market expansion because they are witnessing improvements in healthcare infrastructure while medical technology receives increased investment. Emerging patient care systems will bring about revolutionary changes through the creation of devices that perform real-time data analysis and develop adaptive therapeutic responses.
On the back of the aforementioned facts, the neurology devices market is anticipated to grow at a CAGR of 6.7% during the forecast period from 2025 to 2035, According to the Fact.MR, a market research and competitive intelligence provider.
Market Dynamics
What are the factors propelling global sales of neurology devices?
“Increasing Prevalence of Neurological Disorders”
Neurological disease accompanies a range of causes, symptoms, and ramifications, including a range of ramifications that include curable, and curable, and curable, and preventive. The most complete estimate of neurological loss in terms of overall disease and loss of health in the whole world is in a new report, in a group of 37 specific neurological ailments, an expansion of a group of 15 neurological ailments. 3.4 billion, 43.1%, of the population in 2021 in the whole world lived with a neurological disease, and 11.1 million deaths in 2021 in neurological disease.
The ten neurological ailments with most DALYS in the report included: stroke, neonatal encephalopathy (a neurological disorder in a baby at or about birth), migraine, Alzheimer’s disease and dementia, diabetic neuropathy (nerve disease in a sign of diabetes), meningitis, epilepsy, neurological complications in a baby delivered too early, and nervous system caner and autism spectrum disorder.
The increasing world prevalence of neurological diseases including Alzheimer's disease along with Parkinson's disease and epilepsy drives the market need for state-of-the-art neurology medical equipment. The World Health Organization reports neurological disorders stand as the top disability origin and position as the second most frequent reason for human fatalities across the globe. These rising neurological disease cases demand new decisive medical equipment and therapeutic devices for effective treatment.
The continuous progress in technology resulted in developing neurology devices that are both efficient and minimally invasive. Neurostimulation technology advancements now provide better methods to treat both chronic pain and movement disorders. The market growth has been driven by the implementation of artificial intelligence and machine learning technologies that enhance both efficiency and accuracy in neurological diagnostic testing.
What are the challenges encountered by manufacturers of neurology devices?
“High Cost of Neurology Devices and Procedures”
The excessive price of advanced neurology devices functions as a substantial obstacle to their mass usage since they limit their accessibility in low- and middle-income countries. High investment costs for these devices along with their medical procedures act as market deterrents because they restrict patient and provider access to advanced neurology services.
Country-wise Insights
Why is adoption of neurology devices high in the united states?
“Robust Healthcare Infrastructure Driving Market Growth”
The market in the United States is estimated at USD 3,727 million in 2025 and is projected to expand at a CAGR of 7.4% through 2035. This market is projected to generate a USD 3,917 million absolute $ opportunity from 2025 to 2035. The United States maintains a strong healthcare infrastructure that makes possible fast deployment of state-of-the-art neurology equipment.
Research funding increases alongside positive payment rules to strengthen market growth. The country maintains its leadership position in the neurology devices market because of major market players combined with continuous technological advancements.
The rising frequency of neurological disorders across the United States creates an enhanced market need for useful medical equipment for diagnosis and therapy. The market for neurology devices experiences growth because the aging population combines with lifestyle factors to increase cases of Alzheimer's disease and Parkinson's disease.
Why is china a lucrative market for neurology devices?
“Expanding Healthcare Infrastructure and Access”
China achieved remarkable improvements in healthcare infrastructure and health service access through its rapid economic development. Government proposals to extend healthcare offerings into rural territories boosted medical device demand which includes necessary equipment for neurology practice. Modernization initiatives for healthcare systems in the country will stimulate the adoption of advanced neurology medical equipment.
China reinforces its medical advancement by raising investments in research development which promotes neurology device innovations. Domestic companies working with international enterprises have established partnerships that allow mutual technology exchanges to develop contemporary diagnostic and therapeutic devices for neurological conditions.
Category-wise Insights
The high position of neurostimulation devices in the neurology devices market derives from what regulatory factors accelerate their ongoing market expansion?
“Rise in Trauma and Spinal Cord Injuries Incidence Rate is driving the demand for the Neurostimulation Devices”
Demand for neurostimulation devices is projected to increase at a CAGR of 7.1% from 2025 to 2035. The neurostimulation devices control the neurology devices market due to extensive clinical usage which enables the treatment of Parkinson’s disease alongside epilepsy and chronic pain and depression. The market demand has increased substantially because of both rising prevalence numbers of these conditions and the rising preference for non-invasive procedures.
New technological developments including deep brain stimulation (DBS), spinal cord stimulation (SCS) and transcranial magnetic stimulation (TMS) have delivered better precision and effectiveness of these devices which increases patient success rates. The market experiences further growth because of the incorporation of artificial intelligence together with machine learning processes for continuous monitoring and customized therapeutic practices.
The long-term demand stabilizes because older populations continue to increase in present-day developed nations. The segment’s market position receives additional support from both positive reimbursement policies and expanded research funding for neuromodulation therapies. The global market for neurostimulation devices predicts continued development based on ongoing product improvements and escalating both clinical usages and patient understanding.
Which end-user segment is leading in the global neurology devices?
“Advanced Healthcare Facilities and Growing Patient Admissions Rate is Boosting End-user Segments”
Hospital and ambulatory surgery center is estimated to account for 67.8% share together of the market in 2025. Neurology devices find their basis in hospital and ambulatory surgery center ecosystems because these medical facilities serve as diagnosing and treatment spaces for neurological disorders. The substantial rise in hospital-induced brain surgery and stroke treatment along with neurorehabilitative care has established this segment's dominance of the market.
Hospitals together with ambulatory surgery centers rely on innovative neurology devices because of developments in robotic neurosurgery and image-assisted procedures. High-precision diagnostic and therapeutic tools can be used widely since healthcare facilities have neurosurgeons with advanced training and adequate infrastructure.
Healthcare infrastructure improvements due to public and private investment funds particularly affect developing countries and strengthen the growth of hospitals and specialized neurological centers. ASC market expansion has been fueled by patient demand for ambulatory care options because patients benefit from affordable and shorter hospital stays.
The combination of escalating neurological disorder rates with modern technology improvements and increasing health expenditure places hospitals together with ASCs as the leading users of neurology devices across global markets.
Competitive Landscape
Key players in the neurology devices market are Medtronic, Boston Scientific Corporation, Stryker Corporation, Abbott Laboratories, Johnson & Johnson (DePuy Synthes), Penumbra, Inc., MicroPort Scientific Corporation, Terumo Corporation, Nihon Kohden Corporation, Integra LifeSciences Holdings Corp, Elekta AB, LivaNova PLC, NeuroPace, Inc., NeuroSigma, Inc., and BrainsWay Ltd among others.
Companies devote a significant portion of their revenue to R&D to resolve problems and offer creative solutions to draw in new customers and stay competitive. Companies are developing customized offerings for issues that meet industry-specific needs to compete with other players.
- In September 2024, the Barcelona-based company Inbrain Neuroelectronics introduced its first brain implant built with graphene. The 64 graphene-electrode device functions as a precise neural activity stimulator and reader seeking to enhance brain cancer surgery results and providing potential treatments for Parkinson's disease and epilepsy.
Fact.MR has provided detailed information about the price points of key manufacturers of neurology devices positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
